Evaluation of alpha methyl dopa and alpha methyl dopa hydrazine with L-dopa therapy.
D000328:Adult; D000368:Aged; D002230:Carbidopa / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D008750:Methyldopa / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*
D006834:Hydrazines; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D002230:Carbidopa